Ligand Pharmaceuticals LGND
$286.85 −$0.09 (-0.03%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $286.85 0.00%
Open$285.21
Prev close$286.94
Day range$282.36 – $291.36
Volume259.8K
Market cap$5.74B
P/E (TTM)115.2
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$78.75M-31.8% YoY
Operating profit-$9.49M-117.5% YoY
Net profit-$28.49M-124.3% YoY
Diluted EPS-$1.43-125.2% YoY
Free cash flow-$57.60M-1,329.7% YoY
Operating cash flow-$27.59M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin95.2%
Operating margin14.4%
Net margin20.3%
Return on equity5.4%
Return on assets2.8%
Return on invested capital1.9%
Current ratio1.22
Liabilities / assets57.0%
Cash & investments$474.89M
Total debt$1.15B
Net cash (debt)-$674.76M
Free cash flow / sales22.6%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $78.75M | $63.69M | $51.72M | $268.09M | $59.67M |
| Total Operating Revenue | $78.75M | $63.69M | $51.72M | $268.09M | $59.67M |
| Cost of Revenue | $2.65M | $3.21M | $3.27M | $14.55M | $2.99M |
| Gross Profit | $76.10M | $60.48M | $48.45M | $253.54M | $56.67M |
| Operating Expense | $85.59M | $51.89M | $31.08M | $206.34M | $36.63M |
| Selling and Admin Expenses | $72.62M | $29.12M | $20.84M | $92.45M | $25.03M |
| -General & Admin Expense | $72.62M | $29.12M | $20.84M | $92.45M | $25.03M |
| Research & Development | $2.77M | $14.67M | $2.15M | $81.18M | $3.51M |
| Depreciation & Amortization & Depletion | $10.21M | $8.10M | $8.10M | $32.71M | $8.10M |
| -Depreciation & Amortization | $10.21M | $8.10M | $8.10M | $32.71M | $8.10M |
| Operating Profit | -$9.49M | $8.59M | $17.37M | $47.20M | $20.04M |
| Net Non-Operating Interest Income (Expense) | $2.59M | $5.55M | $4.91M | $8.94M | $4.61M |
| Non-Operating Interest Income | $5.49M | $7.30M | $6.66M | $13.66M | $6.39M |
| Non-Operating Interest Expense | $2.90M | $1.75M | $1.75M | $4.72M | $1.79M |
| Other Income (Expense) | -$37.20M | $50.16M | -$46.54M | $102.82M | $32.13M |
| Gain on Sale of Security | -$3.82M | $11.75M | $3.87M | $18.43M | $22.06M |
| Earnings from Equity Interest | -$35.73M | $35.73M | -$49.23M | $90.67M | $14.78M |
| Special Income (Charges) | -$6.27M | – | – | -$6.20M | -$4.72M |
| -Less:Restructuring and Mergern & Acquisition | $6.27M | – | – | – | – |
| Other Non-Operating Income (Expenses) | $8.61M | $2.68M | -$1.18M | -$89,000.00 | $8,000.00 |
| Pretax Profit | -$44.09M | $64.30M | -$24.26M | $158.96M | $56.78M |
| Tax | -$15.61M | $15.80M | -$10.91M | $34.51M | $12.00M |
| Net Profit | -$28.49M | $48.51M | -$13.35M | $124.45M | $44.78M |
| Profit from Continuing Operations | -$28.49M | $48.51M | -$13.35M | $124.45M | $44.78M |
| Net Income to Parent Company | -$28.49M | $48.51M | -$13.35M | $124.45M | $44.78M |
| Net Income to Common Stockholders | -$28.49M | $48.51M | -$13.35M | $124.45M | $44.78M |
| Basic EPS | -$1.43 | $2.42 | -$0.67 | $6.44 | $2.27 |
| Diluted EPS | -$1.43 | $2.22 | -$0.67 | $6.13 | $2.12 |
| -Less:Write Off | – | – | – | $6.20M | $6.20M |
| -Gain on Sale Of Business | – | – | – | $0.00 | – |
| Net Income from Discontinuous Operations | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $2.24B | $2.19B | $1.53B | $1.56B | $1.56B |
| Total Current Assets | $608.23M | $1.46B | $865.42M | $832.27M | $832.27M |
| Cash and Cash Equivalents & Short-Term Investments | $474.89M | $1.37B | $791.56M | $756.31M | $756.31M |
| -Cash and Cash Equivalents | $55.96M | $1.01B | $115.08M | $174.93M | $174.93M |
| -Short Term Investments | $418.93M | $364.04M | $676.48M | $581.39M | $581.39M |
| Receivables | $107.52M | $69.92M | $54.80M | $61.05M | $61.05M |
| -Accounts Receivable | $83.22M | $67.01M | $53.38M | $59.60M | $59.60M |
| -Taxes Receivable | $24.30M | $2.91M | $1.42M | $1.45M | $1.45M |
| Prepaid Assets | $1.60M | $1.60M | $1.80M | – | – |
| Inventory | $12.91M | $8.66M | $11.47M | $9.13M | $9.13M |
| Restricted Cash | $4.11M | – | – | – | – |
| Other Current Assets | $7.21M | $6.19M | $5.80M | $5.79M | $5.79M |
| Total Non-Current Assets | $1.63B | $728.76M | $666.69M | $728.37M | $728.37M |
| Net PPE | $24.22M | $9.84M | $10.28M | $10.79M | $10.79M |
| -Gross PPE | $24.22M | $9.84M | $10.28M | $17.37M | $17.37M |
| Investments and Advances | $915.54M | $351.10M | $312.82M | $364.83M | $364.83M |
| -Available for Sale Securities | $772.62M | $194.23M | $193.54M | $196.88M | $196.88M |
| -Long Term Equity Investment | $48.45M | $42.39M | $31.52M | $46.50M | $46.50M |
| Financial Assets | $29.20M | $17.91M | $13.53M | $15.63M | $15.63M |
| Goodwill and Other Intangible Assets | $509.90M | $310.79M | $318.88M | $326.98M | $326.98M |
| -Goodwill | $207.86M | $101.54M | $101.54M | $101.54M | $101.54M |
| -Other Intangible Assets | $302.04M | $209.24M | $217.34M | $225.44M | $225.44M |
| Non-Current Deferred Assets | $104.12M | $37.12M | $8.47M | $8.35M | $8.35M |
| Other Non-Current Assets | $46.25M | $2.01M | $2.71M | $1.79M | $1.79M |
| Total Liabilities | $1.28B | $1.22B | $534.78M | $543.43M | $543.43M |
| Total Current Liabilities | $500.57M | $46.74M | $40.67M | $37.45M | $37.45M |
| Payables | $9.25M | $14.45M | $9.00M | $6.23M | $6.23M |
| -Accounts Payable | $4.10M | $9.41M | $5.26M | $3.24M | $3.24M |
| -Total Tax Payable | $5.16M | $5.04M | $3.73M | $2.99M | $2.99M |
| Current Accrued Expenses | $25.04M | $24.79M | $25.83M | $22.69M | $22.69M |
| Short-Term Debt and Capital Lease Obligation | $452.87M | $1.08M | $1.09M | $1.10M | $1.10M |
| -Current Debt | $448.31M | – | – | – | – |
| -Current Capital Lease Obligation | $4.56M | $1.08M | $1.09M | $1.10M | $1.10M |
| Current Deferred Liabilities | $621,000.00 | $621,000.00 | $621,000.00 | $621,000.00 | $621,000.00 |
| Other Current Liabilities | $5.20M | $1.17M | $577,000.00 | $422,000.00 | $422,000.00 |
| Total Non-Current Liabilities | $775.13M | $1.17B | $494.12M | $505.98M | $505.98M |
| Long Term Debt and Capital Lease Obligation | $701.34M | $1.13B | $450.89M | $450.40M | $450.40M |
| -Long Term Debt | $679.91M | $1.13B | $446.90M | $446.19M | $446.19M |
| -Long Term Capital Lease Obligation | $21.43M | $3.78M | $3.99M | $4.20M | $4.20M |
| Non-Current Deferred Liabilities | $22.40M | $21.65M | $22.61M | $36.02M | $36.02M |
| Other Non-Current Liabilities | $51.39M | $19.60M | $20.61M | $19.56M | $19.56M |
| Total Equity | $961.76M | $967.52M | $997.32M | $1.02B | $1.02B |
| Stockholders' Equity | $961.76M | $967.52M | $997.32M | $1.02B | $1.02B |
| Capital Stock | $20,000.00 | $20,000.00 | $20,000.00 | $20,000.00 | $20,000.00 |
| -Common Stock | $20,000.00 | $20,000.00 | $20,000.00 | $20,000.00 | $20,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $403.54M | $379.77M | $397.17M | $400.65M | $400.65M |
| Retained Earnings | $554.77M | $583.25M | $594.74M | $608.09M | $608.09M |
| Gains/Losses Not Affecting Retained Earnings | $3.44M | $4.48M | $5.39M | $8.46M | $8.46M |
| -Accumulated Depreciation | – | – | – | -$6.58M | -$6.58M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$27.59M | $24.02M | $48.69M | $49.36M | $45.92M |
| Net cash flow from continuing operations | -$27.59M | $24.02M | $48.69M | $49.36M | $45.92M |
| Net Income from Continuing Operations | -$28.49M | $48.51M | -$13.35M | $124.45M | $44.78M |
| Gain/Loss from Continuing Operations | -$31.84M | -$46.12M | $46.20M | -$171.82M | -$121.26M |
| Depreciation & Depletion & Amortization | $10.32M | $8.22M | $8.22M | $33.78M | $8.21M |
| Deferred Tax | -$12.49M | $12.98M | -$13.53M | $22.68M | $10.57M |
| Other Non-Cash Items | $9.24M | -$5.02M | $6.18M | $4.84M | -$745,000.00 |
| Change in Working Capital | -$47.59M | -$7.00M | $5.89M | -$12.67M | $9.29M |
| -Change in Receivables | -$16.27M | -$13.85M | $6.41M | -$21.74M | -$2.09M |
| -Change in Inventory | -$4.25M | $3.00M | -$4.14M | $4.99M | $2.77M |
| -Change in Payables and Accrued Expense | -$4.39M | $3.25M | $2.71M | $5.88M | $7.35M |
| -Change In Other Working Capital | -$22.68M | $600,000.00 | $902,000.00 | -$1.80M | $1.26M |
| Net cash flow from investing | -$877.99M | $321.12M | -$94.35M | -$377.32M | -$18.10M |
| Net Cash Flow from Continuing Investing Activities | -$877.99M | $321.12M | -$94.35M | -$377.32M | -$18.10M |
| Net PPE Purchase and Sale | -$142,000.00 | -$26,000.00 | -$228,000.00 | -$452,000.00 | -$9,000.00 |
| Net Intangibles Purchase and Sale | -$7.97M | -$119,000.00 | $6.98M | -$601,000.00 | $845,000.00 |
| Net Investment Purchase and Sale | -$55.01M | $321.26M | -$101.10M | -$363.22M | -$14.79M |
| Financing Cash Flow | $4.06M | $546.43M | -$14.13M | $428.22M | $8.33M |
| Net Cash Flow from Continuing Financing Activities | $4.06M | $546.43M | -$14.13M | $428.22M | $8.33M |
| Net Issuance Payments Of Debt | -$195.80M | $699.99M | -$7,000.00 | $353.63M | $6.90M |
| Net Common Stock Issuance | $0.00 | – | – | -$15.00M | $0.00 |
| Proceeds from Stock Option Exercised | $5.62M | $122.70M | $7.65M | $114.89M | $9.30M |
| Net Other Financing Charges | $194.23M | -$216.26M | -$21.78M | -$25.30M | -$7.87M |
| Ending Cash Balance | $103.39M | $1.01B | $115.09M | $174.93M | $174.93M |
| Net Change in Cash | -$901.52M | $891.57M | -$59.79M | $100.26M | $36.14M |
| Beginning Cash Balance | $1.01B | $115.09M | $174.93M | $72.31M | $139.38M |
| Effect of Exchange Rate Changes | -$1.79M | $39,000.00 | -$44,000.00 | $2.36M | -$590,000.00 |
| Free Cash Flow | -$57.60M | $21.35M | $48.46M | $38.05M | $45.26M |
| Net Business Purchase and Sale | – | – | – | -$8.39M | -$303,000.00 |
| Net Other Investing Changes | – | – | – | -$4.66M | -$3.85M |
No comments yet — be the first to weigh in on LGND.
Sign in to join the discussion.